Transvaginal Radiofrequency Ablation: a Therapeutic Option for Managing Symptomatic Uterine Fibroids in Women with Reproductive Desires

Overview

Journal F S Rep

Specialty Reproductive Medicine

Date 2024 Oct 9

PMID 39381652

Authors

Ma Eugenia Marin Martinez

Sara Cruz-Melguizo

Gema Vaquero Arguello

Virginia Engels Calvo

Ma Luisa De la Cruz Conty

Tirso Perez Medina

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate whether transvaginal radiofrequency (RF) ablation of fibroids is a technique that can be offered to women with reproductive desires.

Design: Unicentric, prospective, observational study.

Setting: University Hospital.

Patients: Twenty-seven individuals who desired to become mothers after undergoing RF ablation for symptomatic fibroids.

Interventions: Transvaginal RF ablation for symptomatic fibroids with a maximum total volume of 145 cm.

Main Outcome Measures: The reduction in the size of the fibroids, improvement of symptoms, and reproductive outcomes during the 24 months after the ablation. For patients who achieved pregnancy, we assessed the type of conception, course of gestation, type of delivery, neonatal outcomes, and occurrence of both maternal and fetal complications.

Results: A statistically significant reduction in symptoms related to the fibroids 6 months after the ablation was demonstrated through the implementation of the Symptom Severity Scale. No patient required hospitalization after the procedure, and on average from the third day after intervention, they resumed their work activities without the need for analgesics. Among those patients who attempted pregnancy during the 24-month follow-up period, 73.68 % (14/19) achieved motherhood. There were no cases of uterine rupture, premature birth, or intrauterine fetal death.

Conclusions: Radiofrequency ablation for fibroids seems to be a promising, safe, and low-complexity alternative that does not appear to interfere with the development of a normal term gestation.

References

Rey V, Labrador R, Falcon M, Garcia-Benitez J . Transvaginal Radiofrequency Ablation of Myomas: Technique, Outcomes, and Complications. J Laparoendosc Adv Surg Tech A. 2018; 29(1):24-28. DOI: 10.1089/lap.2018.0293. View

Margueritte F, Adam C, Fauconnier A, Gauthier T . Time to conceive after myomectomy: should we advise a minimum time interval? A systematic review. Reprod Biomed Online. 2021; 43(3):543-552. DOI: 10.1016/j.rbmo.2021.05.016. View

Arnreiter C, Oppelt P . A Systematic Review of the Treatment of Uterine Myomas Using Transcervical Ultrasound-Guided Radiofrequency Ablation with the Sonata System. J Minim Invasive Gynecol. 2021; 28(8):1462-1469. DOI: 10.1016/j.jmig.2021.04.009. View

Nam J . Pregnancy and symptomatic relief following ultrasound-guided transvaginal radiofrequency ablation in patients with adenomyosis. J Obstet Gynaecol Res. 2019; 46(1):124-132. DOI: 10.1111/jog.14145. View

Polin M, Hur H . Radiofrequency Ablation of Uterine Myomas and Pregnancy Outcomes: An Updated Review of the Literature. J Minim Invasive Gynecol. 2022; 29(6):709-715. DOI: 10.1016/j.jmig.2022.01.015. View

Santalla-Hernandez A, Naveiro-Fuentes M, Benito-Villena R, Villegas-Alcazar J, Lopez-Criado M, Lara-Serrano A . Complications of transvaginal radiofrequency ablation of fibroids: A 5-year experience. Eur J Obstet Gynecol Reprod Biol X. 2023; 20:100244. PMC: 10587728. DOI: 10.1016/j.eurox.2023.100244. View

Tanos V, Toney Z . Uterine scar rupture - Prediction, prevention, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol. 2019; 59:115-131. DOI: 10.1016/j.bpobgyn.2019.01.009. View

Santalla-Hernandez A, Naveiro-Fuentes M, Benito-Villena R, Lopez-Criado M, Gonzalez-Paredes A, Fernandez-Parra J . Efficacy, Complications, and Factors Predictive of Response to Treatment with Transvaginal Radiofrequency Ablation for Symptomatic Uterine Myomas. J Minim Invasive Gynecol. 2022; 29(6):743-752. DOI: 10.1016/j.jmig.2022.01.011. View

Laughlin-Tommaso S, Hesley G, Hopkins M, Brandt K, Zhu Y, Stewart E . Clinical limitations of the International Federation of Gynecology and Obstetrics (FIGO) classification of uterine fibroids. Int J Gynaecol Obstet. 2017; 139(2):143-148. PMC: 5629115. DOI: 10.1002/ijgo.12266. View

10.

. Myomas and reproductive function. Fertil Steril. 2008; 90(5 Suppl):S125-30. DOI: 10.1016/j.fertnstert.2008.09.012. View

11.

Stewart E . Clinical practice. Uterine fibroids. N Engl J Med. 2015; 372(17):1646-55. DOI: 10.1056/NEJMcp1411029. View

12.

Seracchioli R, Rossi S, Govoni F, Rossi E, Venturoli S, Bulletti C . Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy. Hum Reprod. 2000; 15(12):2663-8. DOI: 10.1093/humrep/15.12.2663. View

13.

Ziemlewicz T, Wells S, Lubner M, Brace C, Lee Jr F, Hinshaw J . Hepatic Tumor Ablation. Surg Clin North Am. 2016; 96(2):315-39. DOI: 10.1016/j.suc.2015.12.006. View

14.

Styer A, Rueda B . The Epidemiology and Genetics of Uterine Leiomyoma. Best Pract Res Clin Obstet Gynaecol. 2016; 34:3-12. DOI: 10.1016/j.bpobgyn.2015.11.018. View

15.

Vilos G, Allaire C, Laberge P, Leyland N . The management of uterine leiomyomas. J Obstet Gynaecol Can. 2015; 37(2):157-178. DOI: 10.1016/S1701-2163(15)30338-8. View

16.

Coyne K, Margolis M, Murphy J, Spies J . Validation of the UFS-QOL-hysterectomy questionnaire: modifying an existing measure for comparative effectiveness research. Value Health. 2012; 15(5):674-9. DOI: 10.1016/j.jval.2012.03.1387. View

17.

Brolmann H, Bongers M, Garza-Leal J, Gupta J, Veersema S, Quartero R . The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids. Gynecol Surg. 2016; 13:27-35. PMC: 4753243. DOI: 10.1007/s10397-015-0915-3. View

18.

Keltz J, Levie M, Chudnoff S . Pregnancy Outcomes After Direct Uterine Myoma Thermal Ablation: Review of the Literature. J Minim Invasive Gynecol. 2017; 24(4):538-545. DOI: 10.1016/j.jmig.2017.01.009. View

19.

Van den Bosch T, Dueholm M, Leone F, Valentin L, Rasmussen C, Votino A . Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group. Ultrasound Obstet Gynecol. 2015; 46(3):284-98. DOI: 10.1002/uog.14806. View

20.

Brooks E, Mihalov L, Delvadia D, Hudgens J, Mama S, Makai G . The INSPIRE Comparative Cost Study: 12-Month Health Economic and Clinical Outcomes Associated with Hysterectomy, Myomectomy, and Treatment with the Sonata System. Clinicoecon Outcomes Res. 2020; 12:1-11. PMC: 6955606. DOI: 10.2147/CEOR.S214755. View